August 01, 2014 4:51 AM ET

Biotechnology

Company Overview of Stemgent, Inc.

Company Overview

Stemgent, Inc. develops technology and application solutions for the advancement of stem cell research. The company offers a set of tools for generating induced pluripotent stem (iPS) cells, as well as small molecules, non-viral and viral reprogramming technologies, transfection reagents, cytokines, cell lines, antibodies, and cell culture media. Its products include antibodies for live staining of ES/iPS cells; purified and conjugated antibodies; alkaline phosphatase kits; XF/FF medium and cell culture reagents of human ES/iPS cells; WIT media system for breast cancer research; human fibroblast cell line for the generation of iPS cells; characterized mouse primary iPS cell lines; high-purit...

One Kendall Square Street 2

Suite B6201

Cambridge, MA 02139

United States

Founded in 2007

Phone:

617-245-0000

Fax:

617-494-0398

Key Executives for Stemgent, Inc.

Executive Chairman
Age: 53
Director of Sales and Marketing
Compensation as of Fiscal Year 2014.

Stemgent, Inc. Key Developments

Cellectis bioresearch SAS Announces Collaboration with Stemgent, Inc

Cellectis bioresearch SAS announced collaboration agreement with Stemgent Inc. to provide research services that combines mRNA reprogramming technology and genome engineering. The partnership marries Cellectis bioresearch's leadership in genome engineering with Stemgent's expertise in cellular reprogramming.

Similar Private Companies By Industry

Company Name Region
Arcturus Therapeutics, Inc. United States
Perlstein Lab PBC United States
Aries Scientific, Inc. United States
Organogenesis Inc. United States
Strategic Science & Technologies, LLC United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Stemgent, Inc., please visit www.stemgent.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.